Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Sarcoma × Radiosurgery × Clear all

Phase

Status

Completed 5 Terminated 2 Recruiting 2 Active not recruiting 2 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 14 Brain Neoplasms 10 Carcinoma, Hepatocellular 9 Neoplasm Metastasis 7 Neoplasms 6 Pancreatic Neoplasms 5 Lung Neoplasms 5 Colorectal Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Prostatic Neoplasms 3 Melanoma 3 Carcinoma, Renal Cell 3 Breast Neoplasms 3 Glioblastoma 2 Adenocarcinoma of Lung 2 Triple Negative Breast Neoplasms 1 Sarcoma 1 Recurrence 1 Radiotherapy 1 Prostate Cancer Metastatic 1 Ovarian Neoplasms 1 Neoplasm, Residual 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Liver Diseases 1 Kidney Neoplasms 1 Glioma 1 Carcinoma, Transitional Cell 1 Carcinoma, Merkel Cell 1

Interventions

Radiotherapy 5 Gemcitabine 4 Cyclophosphamide 4 pazopanib 3 Docetaxel 3 Biopsy 3 pembrolizumab 2 olaparib 2 liposomal doxorubicin 2 Vincristine 2 Trastuzumab 2 Trabectedin 2 Temozolomide 2 Taxes 2 Surgical Procedures, Operative 2 Specimen Handling 2 Proton Therapy 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Ifosfamide 2 Filgrastim 2 Etoposide 2 Drug Therapy 2 Doxorubicin 2 Celecoxib 2 Carboplatin 2 Ascorbic Acid 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 trastuzumab biosimilar HLX02 1 tozuleristide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02706171 2024-03-15

Stereotactic Radiosurgery for Soft Tissue Sarcoma

The Cooper Health System

Phase NA Withdrawn

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡